Shares in Moderna Inc. performs better on Monday than competitors

Shares of Moderna Inc. MRNA,
-9.72%
slipped 9.72% to $ 111.40 on Monday, with a comprehensive stock market trading session, with the NASDAQ Composite Index COMP,
+ 0.74%
increased by 0.74% to 12,899.42 and the Dow Jones Industrial Average DJIA,
+ 0.68%
increased by 0.68% to 30,403.97. This was the second consecutive losing day of the stock. Moderna Inc. closed $ 67.10 below the 52-week high ($ 178.50) the company reached on December 1st.

The stock underperformed some of its competitors Monday as AbbVie Inc. ABBV,
+ 0.18%
rose 0.18% to $ 103.45, Amgen Inc. AMGN,
+ 0.32%
increased by 0.32% to $ 223.65, and AstraZeneca PLC ADR AZN,
+ 1.77%
rose 1.77% to $ 49.38. The trading volume (30.7 million) obscured its 50-day average volume of 23.1 million.

Editor’s Note: This story was automatically generated by Automated Insights using Dow Jones and FactSet data. See our Terms of Use for Market Data.

.Source